Overview

Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

The main purpose of this trial is to compare the efficacy and safety of diclofenac diethylamine 2.32% gel applied twice (b.i.d) or three times a day (t.i.d.) with placebo in the treatment of acute ankle sprains (distortions).

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Diclofenac